If incompatible blood types are mixed during a transfusion, the recipient’s immune system attacks the donated red blood cells and destroys them. This triggers a chain reaction that can damage organs, cause uncontrolled bleeding, and in severe cases, be fatal. The reaction can begin within minutes, which is why hospitals test blood carefully before every transfusion.
Why Blood Types Are Incompatible
Your blood type is determined by sugar molecules (antigens) sitting on the surface of your red blood cells. Each red blood cell carries roughly one million of these antigens. Type A blood has one kind of sugar antigen, type B has a different one, type AB has both, and type O has neither. Your immune system naturally produces antibodies against whichever antigens you don’t carry. So if you’re type A, your blood already contains antibodies that will attack type B cells on contact.
Beyond the A and B system, there’s also the Rh factor, a protein on red blood cells that makes your blood either “positive” or “negative.” Someone who is Rh-negative can develop antibodies against Rh-positive blood after exposure. This is why O-negative blood is considered the universal donor type: it lacks A antigens, B antigens, and the Rh protein, so there’s nothing on those cells for a recipient’s immune system to target.
What Happens Inside the Body
When mismatched blood enters your bloodstream, two forms of destruction can occur. The more dangerous one is intravascular hemolysis, where antibodies latch onto the foreign red blood cells and activate a cascade of immune proteins that punch holes in the cells right inside your blood vessels. The cells burst open, spilling their contents into your bloodstream. The second form, extravascular hemolysis, is slower: your immune system tags the foreign cells, and then specialized cleanup cells in the liver, spleen, and bone marrow engulf and digest them.
Both forms release large amounts of hemoglobin, the oxygen-carrying molecule normally locked safely inside red blood cells. Free-floating hemoglobin is toxic. As it passes through the kidneys, it undergoes chemical changes that generate free heme, a highly reactive molecule that damages the delicate tubes responsible for filtering your blood. Free heme triggers intense oxidative stress in kidney tissue, essentially burning through cell membranes and creating toxic byproducts. This can lead to acute kidney injury, one of the most serious complications of a mismatched transfusion.
Symptoms and Timeline
Acute reactions typically begin within the first hour of a transfusion, though they can appear anytime within the first 24 hours. The earliest signs include fever, low back pain, and a drop in blood pressure. Some people feel a sense of dread or chest tightness. Urine may turn dark red or brown as destroyed hemoglobin filters through the kidneys.
In severe cases, the immune reaction spirals into a condition called disseminated intravascular coagulation, where tiny blood clots form throughout the body’s blood vessels. This uses up the blood’s clotting factors so quickly that it paradoxically causes uncontrolled bleeding. It progresses through two stages: widespread clotting first, then dangerous bleeding. The clots themselves can block blood flow and damage organs.
Not all reactions are immediate. Delayed hemolytic reactions can appear anywhere from 24 hours to 30 days after a transfusion. These develop more slowly and with subtler symptoms, often resembling a low-grade illness rather than an emergency. They happen when the recipient’s immune system has a “memory” of a foreign blood antigen from a prior transfusion or pregnancy and gradually ramps up antibody production after re-exposure.
How Hospitals Prevent Mismatches
Before any transfusion, your blood goes through a series of tests. First, your ABO type is confirmed using two independent methods: one tests your red blood cells directly for A and B antigens, and the other checks your plasma for the corresponding antibodies. Both results must agree. Your Rh status is tested separately using a specific reagent.
Next comes antibody screening, which looks for less common antibodies you might have developed from previous transfusions, pregnancies, or other exposures. Finally, a crossmatch test physically mixes a small sample of donor blood with your blood to check for any visible clumping or destruction. Only when all these steps come back clean is a unit of blood cleared for transfusion. Errors that cause mismatched transfusions are almost always administrative, such as mislabeled samples or mix-ups in patient identification, rather than failures of the testing itself.
Rh Incompatibility in Pregnancy
Blood type mixing doesn’t only happen during transfusions. During pregnancy, small amounts of fetal blood can cross the placenta into the mother’s circulation. If the mother is Rh-negative and the baby is Rh-positive, her immune system may recognize the Rh protein as foreign and begin producing antibodies against it.
The first pregnancy is usually unaffected because it takes time for the mother’s immune system to build a significant antibody response. The danger comes in later pregnancies. If a second baby is also Rh-positive, the mother’s pre-formed antibodies can cross the placenta and attack the baby’s red blood cells. As those cells break down, they release bilirubin, a yellow waste product. Mildly elevated bilirubin causes jaundice. At dangerously high levels, it can cause brain damage, a condition called kernicterus. In the most severe cases, massive red blood cell destruction leads to fluid buildup and swelling throughout the baby’s body.
This is almost entirely preventable today. Rh-negative mothers receive an injection of Rh immune globulin during the second trimester and again within a few days of delivery if the baby turns out to be Rh-positive. The injection works by neutralizing any fetal Rh-positive cells in the mother’s blood before her immune system can react to them. The same injection is given after miscarriages, abortions, and certain prenatal procedures like amniocentesis, since any of these events can allow fetal blood to enter the mother’s circulation.
Why O-Negative Supply Matters
Because O-negative blood lacks the antigens that trigger immune reactions, it’s the only type that can be safely given to virtually any patient in an emergency when there’s no time for testing. This makes it critical for trauma situations, but it also means demand constantly outpaces supply. Only about 7% of the population is O-negative. Hospitals carefully ration their O-negative stock, reserving it for true emergencies and using type-specific blood whenever testing is possible.